Effect and safety of Baloxavir Marboxil in children with influenza: multicenter randomized controlled study
Not Applicable
- Conditions
- Influenza
- Registration Number
- JPRN-UMIN000035028
- Lead Sponsor
- Kyoto Chubu Medical Center Department of Pediatrics
- Brief Summary
The efficacy of baloxavir marboxil was similar to that of NAIs, and there was no difference in side effects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 368
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients or their parents do not accept the assigned drug 2)A symptom duration of more than 48 hours 3)Patients who have any chronic respiratory disease, cardiovascular disease, central nervous disorder, immune dysfunction, or other chronic comorbid condition except asthma 4)Patients with severe influenza virus infection requiring inpatient treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method